Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.

MLA

Pakdaman, Hossein, et al. “Health-Related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Subcutaneous Interferon β-1a in Iran.” International Journal of Neuroscience, vol. 127, no. 6, June 2017, pp. 501–07. EBSCOhost, https://doi.org/10.1080/00207454.2016.1198793.

APA

Pakdaman, H., Amini Harandi, A., Gharagozli, K., Abbasi, M., Tabassi, A., Ashrafi, F., Ghaffarpor, M., Sharifi, S., Delavar Kasmae, H., Assarzadegan, F., Arabahmadi, M., & Behnam, B. (2017). Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran. International Journal of Neuroscience, 127(6), 501–507. https://doi.org/10.1080/00207454.2016.1198793

Chicago

Pakdaman, Hossein, Ali Amini Harandi, Koroush Gharagozli, Mehdi Abbasi, Abdolreza Tabassi, Farzad Ashrafi, Majid Ghaffarpor, et al. 2017. “Health-Related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Subcutaneous Interferon β-1a in Iran.” International Journal of Neuroscience 127 (6): 501–7. doi:10.1080/00207454.2016.1198793.